P. Biswal and B. Mallick,"miR-185–5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9", DNA Repair, vol.142, no.103750, pp.1-15, Elsevier, October 2024, 10.1016/j.dnarep.2024.103750       Article

R. Nayak and B. Mallick,"BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening", Cancer Genetics, vol.288–289, pp.20-31, Elsevier 2024, 10.1016/j.cancergen.2024.08.082       Article

P. Gupta and B. Mallick,"miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting", Molecular Biology Reports, vol.51, no.1107, pp.1-26, Springer Nature, December 2024, 10.1007/s11033-024-10040-7       Article

B. Saha, S. Chakravarty, S. Ray, H. Saha, K. Das, I. Ghosh, B. Mallick, N. K. Biswas, and S. Goswami,"Correlating tissue and plasma-specific piRNA changes to predict their possible role in pancreatic malignancy and chronic inflammation", Biomedical Reports, vol.21, no.186, pp.1-14, Spandidos Publications, October 2024, 10.3892/br.2024.1874       Article

S. Biswal and B. Mallick,"Unlocking the potential of signature-based drug repurposing for anticancer drug discovery", Archives of Biochemistry and Biophysics, vol.761, no.110150, pp.1-12, Elsevier, November 2024, 10.1016/j.abb.2024.110150       Article

T. Chattopadhyay and B. Mallick,"FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma", Life Sciences, vol.329, no.121954, pp.1-19, Elsevier, July 2023, 10.1016/j.lfs.2023.121954       Article

P. Gupta, G. Das, T. Chattopadhyay, Z. Ghosh, and B. Mallick,"TarpiD, a database of putative and validated targets of piRNAs", Molecular Omics, vol.19, pp.706-713, RSC, November 2023, 10.1039/D3MO00098B       Article

R. Nayak, T. Chattopadhyay, P. Gupta, and B. Mallick,"Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma", Molecular Omics, vol.19, pp.252-261, RSC, March 2023, 10.1039/D2MO00245K       Article

T. Chattopadhyay and B. Mallick,"FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma", Life Sciences, vol.329, no.121954, pp.1-19, Elsevier, September 2023, 10.1016/j.lfs.2023.121954       Article

R. Nayak and B. Mallick,"LncRNA-associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastoma", Journal of Molecular Recognition, vol.36, no.12, pp.1-13, Wiley, December 2023, 10.1002/jmr.3060       Article